Advertisement

Ashwagandha for Brain Health: Experimental Evidence for Its Neuroregenerative Activities

  • Renu Wadhwa
  • Rajkumar S. Kalra
  • Anupama Chaudhary
  • Sunil C. Kaul
Chapter

Abstract

Rapidly growing population, social and environmental factors are continuously exerting impact on social and psychological human health in multiple ways. In particular, these factors cause cumulative stress affecting cognitive functions and elevate risks of diverse neuronal dysfunction and malignant brain diseases. Maintenance of brain health has hence emerged as a new challenge in increasing old age populations worldwide. Use of herbal drug constituents has emerged as a preferred choice due to enormous undesirable side effects of pharmacological drugs. Ashwagandha, a sub-tropical medicinal plant has been extensively used in Indian traditional home medicine system i.e. called “Ayurveda” for its stress-, hypertension-, aging-, neurological dysfunction- and malignant growth-inhibitory properties. Detailed molecular insights of these activities and mechanism(s) are only beginning to be demonstrated by laboratory studies. In this chapter, we attempt to sketch research evidence of the benefits of Ashwagandha bioactives for brain health.

Keywords

Ashwagandha Withanolides Neurodegenerative disease Neuroprotection Brain health 

References

  1. Agnihotri AP, Sontakke SD, Thawani VR, Saoji A, Goswami VS (2013) Effects of Withania somnifera in patients of schizophrenia: a randomized, double blind, placebo controlled pilot trial study. Indian J Pharmacol 45:417–418PubMedPubMedCentralCrossRefGoogle Scholar
  2. Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN, Islam F (2005) Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24:137–147PubMedCrossRefGoogle Scholar
  3. Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, Shankhwar SN, Ahmad S (2010) Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril 94:989–996PubMedCrossRefGoogle Scholar
  4. Ahmed ME, Javed H, Khan MM, Vaibhav K, Ahmad A, Khan A, Tabassum R, Islam F, Safhi MM, Islam F (2013) Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment. Protoplasma 250:1067–1078PubMedCrossRefGoogle Scholar
  5. Akula KK, Dhir A, Kulkarni SK (2009) Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. Methods Find Exp Clin Pharmacol 31:423–432PubMedCrossRefGoogle Scholar
  6. Ali SA, Meitei KV (2011) On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores. J Recept Signal Transduct Res 31:359–366PubMedCrossRefGoogle Scholar
  7. Andrade C (2009) Ashwagandha for anxiety disorders. World J Biol Psychiatry 10:686–687PubMedCrossRefGoogle Scholar
  8. Antony ML, Lee J, Hahm ER, Kim SH, Marcus AI, Kumari V, Ji X, Yang Z, Vowell CL, Wipf P, Uechi GT, Yates NA, Romero G, Sarkar SN, Singh SV (2014) Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of beta-tubulin. J Biol Chem 289:1852–1865PubMedCrossRefGoogle Scholar
  9. Anwer T, Sharma M, Pillai KK, Khan G (2012) Protective effect of Withania somnifera against oxidative stress and pancreatic beta-cell damage in type 2 diabetic rats. Acta Pol Pharm 69:1095–1101PubMedGoogle Scholar
  10. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK (2007) Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord 13:230–239PubMedCrossRefGoogle Scholar
  11. Baitharu I, Jain V, Deep SN, Hota KB, Hota SK, Prasad D, Ilavazhagan G (2013) Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J Ethnopharmacol 145:431–441PubMedCrossRefGoogle Scholar
  12. Bhattacharya A, Ghosal S, Bhattacharya SK (2001) Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 74:1–6PubMedCrossRefGoogle Scholar
  13. Bhattacharya A, Muruganandam AV, Kumar V, Bhattacharya SK (2002) Effect of poly herbal formulation, EuMil, on neurochemical perturbations induced by chronic stress. Indian J Exp Biol 40:1161–1163PubMedGoogle Scholar
  14. Bhattacharya A, Ramanathan M, Ghosal S, Bhattacharya SK (2000a) Effect of Withania somnifera glycowithanolides on iron-induced hepatotoxicity in rats. Phytother Res 14:568–570PubMedCrossRefGoogle Scholar
  15. Bhattacharya SK, Bhattacharya A, Chakrabarti A (2000b) Adaptogenic activity of Siotone, a polyherbal formulation of Ayurvedic rasayanas. Indian J Exp Biol 38:119–128PubMedGoogle Scholar
  16. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S (2000c) Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 7:463–469PubMedCrossRefGoogle Scholar
  17. Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75:547–555PubMedCrossRefGoogle Scholar
  18. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788PubMedCrossRefGoogle Scholar
  19. Chandrasekhar K, Kapoor J, Anishetty S (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 34:255–262PubMedPubMedCentralCrossRefGoogle Scholar
  20. Chatterjee S, Rao AT, Das SN, Agrawal SK (2001) Anti-atherogenic Action of “Cardipro” – A Herbal Proprietary Formulation. Anc Sci Life 20:81–85PubMedPubMedCentralGoogle Scholar
  21. Chaudhary G, Sharma U, Jagannathan NR, Gupta YK (2003) Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 30:399–404PubMedCrossRefGoogle Scholar
  22. Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R (2013) Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry 74:1076–1083PubMedCrossRefGoogle Scholar
  23. Choudhary MI, Nawaz SA, ul-Haq Z, Lodhi MA, Ghayur MN, Jalil S, Riaz N, Yousuf S, Malik A, Gilani AH, ur-Rahman A (2005) Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophys Res Commun 334:276–287PubMedCrossRefGoogle Scholar
  24. Choudhary MI, Yousuf S, Nawaz SA, Ahmed S, Atta ur R (2004) Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo) 52:1358–1361CrossRefGoogle Scholar
  25. Choudhary S, Kumar P, Malik J (2013) Plants and phytochemicals for Huntington’s disease. Pharmacogn Rev 7:81–91PubMedPubMedCentralCrossRefGoogle Scholar
  26. Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, Seely D (2009) Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One 4:e6628PubMedPubMedCentralCrossRefGoogle Scholar
  27. Dar PA, Singh LR, Kamal MA, Dar TA (2016) Unique Medicinal Properties of Withania Somnifera: Phytochemical Constituents and Protein Component. Curr Pharm Des 22:535–540PubMedCrossRefGoogle Scholar
  28. Davis L, Kuttan G (1998) Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol 62:209–214PubMedCrossRefGoogle Scholar
  29. Devi PU (1996) Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 34:927–932PubMedGoogle Scholar
  30. Felicio AC, Dinelle K, Agarwal PA, McKenzie J, Heffernan N, Road JD, Appel-Cresswell S, Wszolek ZK, Farrer MJ, Schulzer M, Sossi V, Stoessl AJ (2014) In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers. Mov Disord 29:1197–1201PubMedPubMedCentralCrossRefGoogle Scholar
  31. Gao R, Shah N, Lee JS, Katiyar SP, Li L, Oh E, Sundar D, Yun CO, Kaul SC, Wadhwa R (2014) Withanone Rich Combination of Ashwagandha Withanolides Restricts Metastasis And Angiogenesis Through hnRNP-K. Mol Cancer Ther 13:2930–2940PubMedCrossRefGoogle Scholar
  32. Gautam A, Kaul SC, Thakur MK (2015) Alcoholic Extract of Ashwagandha Leaves Protects Against Amnesia by Regulation of Arc Function. Mol Neurobiol 53:1760–1769PubMedCrossRefGoogle Scholar
  33. Gautam A, Wadhwa R, Thakur MK (2013) Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves. Neurobiol Learn Mem 106:177–184PubMedCrossRefGoogle Scholar
  34. Grin B, Mahammad S, Wedig T, Cleland MM, Tsai L, Herrmann H, Goldman RD (2012) Withaferin a alters intermediate filament organization, cell shape and behavior. PLoS One 7:e39065PubMedPubMedCentralCrossRefGoogle Scholar
  35. Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D (2012) Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn 29:651–662PubMedCrossRefGoogle Scholar
  36. Gupta GL, Rana AC (2008) Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats. Indian J Exp Biol 46:470–475PubMedGoogle Scholar
  37. Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P, Saxena A, Arya DS (2004) Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 260:39–47PubMedCrossRefGoogle Scholar
  38. Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochem Int 45:583–595PubMedCrossRefGoogle Scholar
  39. Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB (2006) Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Mol Cancer Ther 5:1434–1445PubMedCrossRefGoogle Scholar
  40. Jain S, Shukla SD, Sharma K, Bhatnagar M (2001) Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res 15:544–548PubMedCrossRefGoogle Scholar
  41. Jayaprakasam B, Padmanabhan K, Nair MG (2010) Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer’s disease. Phytother Res 24:859–863PubMedGoogle Scholar
  42. Jena GB, Nemmani KV, Kaul CL, Ramarao P (2003) Protective effect of a polyherbal formulation (Immu-21) against cyclophosphamide-induced mutagenicity in mice. Phytother Res 17:306–310PubMedCrossRefGoogle Scholar
  43. Kasture S, Vinci S, Ibba F, Puddu A, Marongiu M, Murali B, Pisanu A, Lecca D, Zernig G, Acquas E (2009) Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study. Neurotox Res 16:343–355PubMedCrossRefGoogle Scholar
  44. Kataria H, Gupta M, Lakhman S, Kaur G (2015a) Withania somnifera aqueous extract facilitates the expression and release of GnRH: In vitro and in vivo study. Neurochem Int 89:111–119PubMedCrossRefGoogle Scholar
  45. Kataria H, Kumar S, Chaudhary H, Kaur G (2015b) Withania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells. Mol Neurobiol 53:4143–4158PubMedCrossRefGoogle Scholar
  46. Kataria H, Shah N, Kaul SC, Wadhwa R, Kaur G (2011) Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells. Evid Based Complement Alternat Med 2011:267614PubMedPubMedCentralCrossRefGoogle Scholar
  47. Kataria H, Wadhwa R, Kaul SC, Kaur G (2012) Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One 7:e37080PubMedPubMedCentralCrossRefGoogle Scholar
  48. Kataria H, Wadhwa R, Kaul SC, Kaur G (2013) Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas. PLoS One 8:e55316PubMedPubMedCentralCrossRefGoogle Scholar
  49. Kaur K, Rani G, Widodo N, Nagpal A, Taira K, Kaul SC, Wadhwa R (2004) Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chem Toxicol 42:2015–2020PubMedCrossRefGoogle Scholar
  50. Kaur P, Sharma M, Mathur S, Tiwari M, Divekar HM, Kumar R, Srivastava KK, Chandra R (2003) Effect of 1-oxo-5beta, 6beta-epoxy-witha-2-ene-27-ethoxy-olide isolated from the roots of Withania somnifera on stress indices in Wistar rats. J Altern Complement Med 9:897–907PubMedCrossRefGoogle Scholar
  51. Kaurav BP, Wanjari MM, Chandekar A, Chauhan NS, Upmanyu N (2012) Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pac J Trop Med 5:380–384PubMedCrossRefGoogle Scholar
  52. Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R, Thakur MK (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 6:e27265PubMedPubMedCentralCrossRefGoogle Scholar
  53. Krishnamurthy MN, Telles S (2007) Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential home. J Gerontol Nurs 33:17–23PubMedGoogle Scholar
  54. Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961–971PubMedPubMedCentralCrossRefGoogle Scholar
  55. Kuboyama T, Tohda C, Komatsu K (2006) Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur J Neurosci 23:1417–1426PubMedCrossRefGoogle Scholar
  56. Kuboyama T, Tohda C, Komatsu K (2014) Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull 37:892–897PubMedCrossRefGoogle Scholar
  57. Kulkarni SK, Akula KK, Dhir A (2008a) Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system. Indian J Exp Biol 46:465–469PubMedGoogle Scholar
  58. Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 32:1093–1105PubMedCrossRefGoogle Scholar
  59. Kulkarni SK, Singh K, Bishnoi M (2008b) Comparative behavioural profile of newer antianxiety drugs on different mazes. Indian J Exp Biol 46:633–638PubMedGoogle Scholar
  60. Kumar A, Kalonia H (2007) Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method). Indian J Exp Biol 45:524–528PubMedGoogle Scholar
  61. Kumar A, Kalonia H (2008) Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic Mechanism. Indian J Pharm Sci 70:806–810PubMedPubMedCentralCrossRefGoogle Scholar
  62. Kumar A, Kulkarni SK (2006) Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice. Indian J Exp Biol 44:45–48PubMedGoogle Scholar
  63. Kumar P, Kumar A (2009) Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington’s disease. J Med Food 12:591–600PubMedCrossRefGoogle Scholar
  64. Kumar P, Singh R, Nazmi A, Lakhanpal D, Kataria H, Kaur G (2014) Glioprotective Effects of Ashwagandha Leaf Extract against Lead Induced Toxicity. Biomed Res Int 2014:182029PubMedPubMedCentralGoogle Scholar
  65. Kumar S, Seal CJ, Howes MJ, Kite GC, Okello EJ (2010) In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and beta-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother Res 24:1567–1574PubMedCrossRefGoogle Scholar
  66. Kumar V, Murthy KN, Bhamid S, Sudha CG, Ravishankar GA (2005) Genetically modified hairy roots of Withania somnifera Dunal: a potent source of rejuvenating principles. Rejuvenation Res 8:37–45PubMedCrossRefGoogle Scholar
  67. Kurapati KR, Atluri VS, Samikkannu T, Nair MP (2013) Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e77624PubMedPubMedCentralCrossRefGoogle Scholar
  68. Kurapati KR, Samikkannu T, Atluri VS, Kaftanovskaya E, Yndart A, Nair MP (2014) beta-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A. PLoS One 9:e112818Google Scholar
  69. Kuttan G (1996) Use of Withania somnifera Dunal as an adjuvant during radiation therapy. Indian J Exp Biol 34:854–856PubMedGoogle Scholar
  70. Lee DH, Lim IH, Sung EG, Kim JY, Song IH, Park YK, Lee TJ (2013a) Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway. Oncol Rep 30:933–938PubMedCrossRefGoogle Scholar
  71. Lee J, Hahm ER, Marcus AI, Singh SV (2013b) Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Mol Carcinog 54:417–429PubMedPubMedCentralCrossRefGoogle Scholar
  72. Lee J, Sehrawat A, Singh SV (2012) Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat 136:45–56PubMedPubMedCentralCrossRefGoogle Scholar
  73. Maity T, Adhikari A, Bhattacharya K, Biswas S, Debnath PK, Maharana CS (2011) A study on evalution of antidepressant effect of imipramine adjunct with Aswagandha and Bramhi. Nepal Med Coll J 13:250–253PubMedGoogle Scholar
  74. Manjunath MJ, Muralidhara (2013) Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. Cent Nerv Syst Agents Med Chem 13:43–56PubMedCrossRefGoogle Scholar
  75. Manjunath NK, Telles S (2005) Influence of Yoga and Ayurveda on self-rated sleep in a geriatric population. Indian J Med Res 121:683–690PubMedGoogle Scholar
  76. Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazon J (2009) Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 14:2373–2393PubMedCrossRefGoogle Scholar
  77. Misra DS, Maiti R, Ghosh D (2009) Protection of swimming-induced oxidative stress in some vital organs by the treatment of composite extract of Withania somnifera, Ocimum sanctum and Zingiber officinalis in male rat. Afr J Tradit Complement Altern Med 6:534–543PubMedPubMedCentralGoogle Scholar
  78. Mohan L, Rao US, Gopalakrishna HN, Nair V (2011) Evaluation of the Anxiolytic Activity of NR-ANX-C (a Polyherbal Formulation) in Ethanol Withdrawal-Induced Anxiety Behavior in Rats. Evid Based Complement Alternat Med 2011:2011Google Scholar
  79. Mohanty IR, Arya DS, Gupta SK (2008) Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr 27:635–642PubMedCrossRefGoogle Scholar
  80. Muruganandam AV, Kumar V, Bhattacharya SK (2002) Effect of poly herbal formulation, EuMil, on chronic stress-induced homeostatic perturbations in rats. Indian J Exp Biol 40:1151–1160PubMedGoogle Scholar
  81. Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohanakumar KP (2000) Association of L-DOPA with recovery following Ayurveda medication in Parkinson’s disease. J Neurol Sci 176:124–127PubMedCrossRefGoogle Scholar
  82. Naidu PS, Singh A, Kulkarni SK (2003) Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action. J Med Food 6:107–114PubMedCrossRefGoogle Scholar
  83. Naidu PS, Singh A, Kulkarni SK (2006) Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res 20:140–146PubMedCrossRefGoogle Scholar
  84. Nair V, Arjuman A, Dorababu P, Gopalakrishna HN, Chakradhar Rao U, Mohan L (2007) Effect of NR-ANX-C (a polyherbal formulation) on haloperidol induced catalepsy in albino mice. Indian J Med Res 126:480–484PubMedGoogle Scholar
  85. Nair V, Arjuman A, Gopalakrishna HN, Nandini M (2008) Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice. Phytother Res 22:243–246PubMedCrossRefGoogle Scholar
  86. Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ (2008) Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 71:1790–1795PubMedPubMedCentralCrossRefGoogle Scholar
  87. Parihar MS, Chaudhary M, Shetty R, Hemnani T (2004) Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 11:397–402PubMedCrossRefGoogle Scholar
  88. Parihar MS, Hemnani T (2003) Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J Biosci 28:121–128PubMedCrossRefGoogle Scholar
  89. Patil SP, Maki S, Khedkar SA, Rigby AC, Chan C (2010) Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance. J Nat Prod 73:1196–1202PubMedPubMedCentralCrossRefGoogle Scholar
  90. Pingali U, Pilli R, Fatima N (2014) Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacognosy Res 6:12–18PubMedPubMedCentralCrossRefGoogle Scholar
  91. Prakash J, Yadav SK, Chouhan S, Singh SP (2013) Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochem Res 38:972–980PubMedCrossRefGoogle Scholar
  92. Pramanik SS, Sur TK, Debnath PK, Bhattacharyya D (2010) Effect of Pueraria tuberosa tuber extract on chronic foot shock stress in Wistar rats. Nepal Med Coll J 12:234–238PubMedGoogle Scholar
  93. Prasad S, Malhotra CL (1968) Studies on Withania ashwagandha Kaul. VI. The effect of the alkaloidal fractions (acetone, alcohol and water soluble) on the central nervous system. Indian J Physiol Pharmacol 12:175–181PubMedGoogle Scholar
  94. Praveenkumar V, Kuttan R, Kuttan G (1994) Chemoprotective action of Rasayanas against cyclosphamide toxicity. Tumori 80:306–308PubMedGoogle Scholar
  95. Priyandoko D, Ishii T, Kaul SC, Wadhwa R (2011) Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolite. PLoS One 6:e19552PubMedPubMedCentralCrossRefGoogle Scholar
  96. Raghavan A, Shah ZA (2014) Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis. Mol Neurobiol 52:1093–1105PubMedCrossRefGoogle Scholar
  97. RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S (2009a) Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouse. J Ethnopharmacol 125:369–373Google Scholar
  98. Rajasankar S, Manivasagam T, Surendran S (2009b) Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s disease. Neurosci Lett 454:11–15PubMedCrossRefGoogle Scholar
  99. Ramanathan M, Balaji B, Justin A (2011) Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model. Indian J Exp Biol 49:269–275PubMedGoogle Scholar
  100. Rasheed A, Satyanarayana KV, Gulabi PS, Rao MS (2013) Chemical and pharmacological standardization of Ashwagandhadi lehyam: an ayurvedic formulation. J Complement Integr Med 15:10Google Scholar
  101. Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, Pandey SN, Vaidya RA, Vaidya AB (2012) Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. J Ayurveda Integr Med 3:111–114PubMedPubMedCentralCrossRefGoogle Scholar
  102. Reuland DJ, Khademi S, Castle CJ, Irwin DC, McCord JM, Miller BF, Hamilton KL (2013) Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic Biol Med 56:102–111PubMedCrossRefGoogle Scholar
  103. Ross OA, Soto-Ortolaza AI, Heckman MG, Verbeeck C, Serie DJ, Rayaprolu S, Rich SS, Nalls MA, Singleton A, Guerreiro R, Kinsella E, Wszolek ZK, Brott TG, Brown RD Jr, Worrall BB, Meschia JF (2013) NOTCH3 variants and risk of ischemic stroke. PLoS One 8:e75035PubMedPubMedCentralCrossRefGoogle Scholar
  104. Russo A, Izzo AA, Cardile V, Borrelli F, Vanella A (2001) Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 8:125–132PubMedCrossRefGoogle Scholar
  105. Sankar SR, Manivasagam T, Krishnamurti A, Ramanathan M (2007) The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett 12:473–481PubMedCrossRefGoogle Scholar
  106. Sarris J, McIntyre E, Camfield DA (2013) Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs 27:301–319PubMedCrossRefGoogle Scholar
  107. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V (1997) Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int 30:181–190PubMedCrossRefGoogle Scholar
  108. Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V (2012) Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 109:3510–3515PubMedPubMedCentralCrossRefGoogle Scholar
  109. Shah N, Kataria H, Kaul SC, Ishii T, Kaur G, Wadhwa R (2009) Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci 100:1740–1747PubMedCrossRefGoogle Scholar
  110. Shah N, Singh R, Sarangi U, Saxena N, Chaudhary A, Kaur G, Kaul SC, Wadhwa R (2015) Combinations of Ashwagandha Leaf Extracts Protect Brain-Derived Cells against Oxidative Stress and Induce Differentiation. PLoS One 10:e0120554PubMedPubMedCentralCrossRefGoogle Scholar
  111. Shreevathsa M, Ravishankar B, Dwivedi R (2013) Anti depressant activity of Mamsyadi Kwatha: An Ayurvedic compound formulation. Ayu 34:113–117PubMedPubMedCentralCrossRefGoogle Scholar
  112. Shukla K, Dikshit P, Tyagi MK, Shukla R, Gambhir JK (2012) Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide-streptozotocin induced diabetes mellitus. Food Chem Toxicol 50:3595–3599PubMedCrossRefGoogle Scholar
  113. Shukla KK, Mahdi AA, Mishra V, Rajender S, Sankhwar SN, Patel D, Das M (2011a) Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations. Reprod Biomed Online 22:421–427PubMedCrossRefGoogle Scholar
  114. Shukla V, Mishra SK, Pant HC (2011b) Oxidative stress in neurodegeneration. Adv Pharmacol Sci 2011:572634PubMedPubMedCentralGoogle Scholar
  115. Singh A, Naidu PS, Gupta S, Kulkarni SK (2002) Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 5:211–220PubMedCrossRefGoogle Scholar
  116. Singh N, Bhalla M, de Jager P, Gilca M (2011) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 8:208–213PubMedPubMedCentralGoogle Scholar
  117. Singh RH, Narsimhamurthy K, Singh G (2008) Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 9:369–374PubMedCrossRefGoogle Scholar
  118. Soman S, Anju TR, Jayanarayanan S, Antony S, Paulose CS (2013) Impaired motor learning attributed to altered AMPA receptor function in the cerebellum of rats with temporal lobe epilepsy: ameliorating effects of Withania somnifera and withanolide A. Epilepsy Behav 27:484–491PubMedCrossRefGoogle Scholar
  119. Soman S, Korah PK, Jayanarayanan S, Mathew J, Paulose CS (2012) Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A. Neurochem Res 37:1915–1927PubMedCrossRefGoogle Scholar
  120. Spector AR, Dugger BN, Wszolek ZK, Uitti RJ, Fredrickson P, Kaplan J, Boeve BF, Dickson DW, Strongosky A, Lin SC (2011) Anatomy of disturbed sleep in pallido-ponto-nigral degeneration. Ann Neurol 69:1014–1025PubMedPubMedCentralCrossRefGoogle Scholar
  121. Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI (2011) Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer 129:2744–2755PubMedCrossRefGoogle Scholar
  122. Tohda C (2008) Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unraveling pathophysiological mechanisms. Yakugaku Zasshi 128:1159–1167PubMedCrossRefGoogle Scholar
  123. Tohda C, Joyashiki E (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. Br J Pharmacol 157:1427–1440PubMedPubMedCentralCrossRefGoogle Scholar
  124. Tripathi AK, Dey S, Singh RH, Dey PK (1998) Alterations in the sensitivity of 5(th) receptor subtypes following chronic asvagandha treatment in rats. Anc Sci Life 17:169–181PubMedPubMedCentralGoogle Scholar
  125. Uitti RJ, Wszolek ZK (2003) Dopamine agonists, sleep disorders, and driving in Parkinson’s disease. Adv Neurol 91:343–349PubMedGoogle Scholar
  126. Vareed SK, Bauer AK, Nair KM, Liu Y, Jayaprakasam B, Nair MG (2014) Blood-Brain Barrier Permeability of Bioactive Withanamides Present in Withania somnifera Fruit Extract. Phytother Res 28:1260–1264PubMedCrossRefGoogle Scholar
  127. Vedi M, Rasool M, Sabina EP (2014) Protective effect of administration of Withania somifera against bromobenzene induced nephrotoxicity and mitochondrial oxidative stress in rats. Ren Fail 36:1095–1103PubMedCrossRefGoogle Scholar
  128. Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M (2010) Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Cent Nerv Syst Agents Med Chem 10:238–246PubMedCrossRefGoogle Scholar
  129. Wscieklica T, de Barros VM, Le Sueur ML, Pouza KC, Spadari RC, Cespedes IC (2016) Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries. Alcohol 50:73–82PubMedCrossRefGoogle Scholar
  130. Yang Z, Garcia A, Xu S, Powell DR, Vertino PM, Singh S, Marcus AI (2013) Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One 8:e75069PubMedPubMedCentralCrossRefGoogle Scholar
  131. Yin H, Cho DH, Park SJ, Han SK (2013) GABA-mimetic actions of Withania somnifera on substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice. Am J Chin Med 41:1043–1051PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Renu Wadhwa
    • 1
  • Rajkumar S. Kalra
    • 1
  • Anupama Chaudhary
    • 1
  • Sunil C. Kaul
    • 1
  1. 1.DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Biomedical Research InstituteNational Institute of Advanced Industrial Science & Technology (AIST)TsukubaJapan

Personalised recommendations